{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:00:04Z","timestamp":1761102004342},"reference-count":30,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.regpep.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T20:50:52Z","timestamp":1340830252000},"page":"11-15","source":"Crossref","is-referenced-by-count":9,"title":["Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study"],"prefix":"10.1016","volume":"178","author":[{"given":"Marcel","family":"Roos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko M.","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"T\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"von Eynatten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2012.06.001_bb0005","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.06.001_bb0010","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.06.001_bb0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.tp.0000190423.82154.01","article-title":"Chronic allograft nephropathy: current concepts and future directions","volume":"81","author":"Nankivell","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.regpep.2012.06.001_bb0020","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/01.tp.0000295982.78039.ef","article-title":"High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients","volume":"84","author":"Van Timmeren","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.regpep.2012.06.001_bb0025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.tp.0000255326.27474.a4","article-title":"Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation","volume":"83","author":"Heinemann","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.regpep.2012.06.001_bb0030","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1681\/ASN.2005040412","article-title":"Expression of surfactant protein-C, S100A9 and B cell markers in renal allografts: investigation of the prognostic value","volume":"16","author":"Eikmans","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.regpep.2012.06.001_bb0035","first-page":"RA55-RA61","article-title":"Adiponectin and resistin: new hormones of white adipose tissue","volume":"9","author":"Beltwoski","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.regpep.2012.06.001_bb0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1373\/clinchem.2008.112425","article-title":"Comparison of immunoassays for the selective measurement of human high\u2010molecular weight adiponectin","volume":"55","author":"Liu","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.regpep.2012.06.001_bb0045","first-page":"e27","article-title":"Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin","volume":"84","author":"Kobayashi","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.regpep.2012.06.001_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diabetes.55.01.06.db05-1105","article-title":"Adiponectin multimeric complexes and the metabolic syndrome trait cluster","volume":"55","author":"Lara-Castro","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.06.001_bb0055","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2337\/db05-1525","article-title":"Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin","volume":"55","author":"Aso","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.06.001_bb0060","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/eurheartj\/ehn135","article-title":"Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease","volume":"29","author":"von Eynatten","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.regpep.2012.06.001_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2007.10.002","article-title":"High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men","volume":"199","author":"von Eynatten","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.regpep.2012.06.001_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000085827","article-title":"Markers of endothelial cell activation\/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients","volume":"25","author":"Malyszko","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.regpep.2012.06.001_bb0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-6143.2006.01646.x","article-title":"Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation","volume":"7","author":"Bayes","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.regpep.2012.06.001_bb0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jc.2003-031012","article-title":"Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation","volume":"89","author":"Tan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.06.001_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11892-007-0006-6","article-title":"Adipokines and vascular disease in diabetes","volume":"7","author":"Goldstein","year":"2007","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.regpep.2012.06.001_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/CS20070347","article-title":"Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention","volume":"114","author":"Zhu","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.regpep.2012.06.001_bb0095","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.transproceed.2005.09.116","article-title":"Endothelial dysfunction in renal transplant recipients","volume":"37","author":"Mark","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.regpep.2012.06.001_bb0100","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.101.9.948","article-title":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction","volume":"101","author":"Suwaidi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2012.06.001_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ncpcardio1398","article-title":"Protective vascular and myocardial effects of adiponectin","volume":"6","author":"Goldstein","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.regpep.2012.06.001_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20050182","article-title":"Adiponectin: a key adipocytokine in metabolic syndrome","volume":"110","author":"Okamoto","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.regpep.2012.06.001_bb0115","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2119\/2007-00111.Maluf","article-title":"Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis","volume":"14","author":"Maluf","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.regpep.2012.06.001_bb0120","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2012.06.001_bb0125","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","article-title":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin","volume":"100","author":"Ouchi","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.regpep.2012.06.001_bb0130","doi-asserted-by":"crossref","first-page":"H2148","DOI":"10.1152\/ajpheart.00907.2011","article-title":"Inflammation and metabolic dysfunction: links to cardiovascular diseases","volume":"302","author":"Taube","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.regpep.2012.06.001_bb0135","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1172\/JCI29623","article-title":"Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo","volume":"117","author":"Ouedraogo","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2012.06.001_bb0140","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1161\/01.RES.0000119921.86460.37","article-title":"Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin","volume":"94","author":"Kobayashi","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.regpep.2012.06.001_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2265.2008.03412.x","article-title":"Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes","volume":"71","author":"von Eynatten","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.regpep.2012.06.001_bb0150","doi-asserted-by":"crossref","first-page":"E1100","DOI":"10.1152\/ajpendo.00187.2006","article-title":"Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes","volume":"5","author":"Bodles","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512001863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512001863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T13:51:47Z","timestamp":1542894707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011512001863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":30,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0167011512001863"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2012.06.001","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}